谭松巍 - 华中科技大学

个人简介

教育及工作经历 2016年至今华中科技大学药学院，副教授 2013-2016年华中科技大学药学院，讲师 2011-2013年华中科技大学药学流动站，博士后 2005-2011年浙江大学高分子科学研究所，理学博士（导师：王利群教授） 2001-2005年浙江大学高分子系，工学学士

研究领域

从事生物医用高分子材料相关研究

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Tian M, Zhou Z,Tan SW, Fan XL*, Li L, Ullah N,Formulation in DDA-MPLA-TDB Liposome Enhances the Immunogenicity and Protective Efficacy of a DNA Vaccine against Mycobacterium tuberculosis Infection,Frontiers in Immunology,2018,9:310. (IF:5.511) •Sun Y, Bao Y, Jiang X,Tan SW*, Yin MX,YangC,Zhou L,ZhangZP*. pH-sensitive micelles with charge-reversible property for tumor growth inhibition and anti-metastasis,Journal of Materials Chemistry B, 2018,6, 458-468.(co-responding author)(IF:4.776) •Song Q, Yin Y, Shang L, Wu T, Zhang D, Kong M, Zhao Y, He Y,Tan SW*, Guo Y,ZhangZP*. Tumor Microenvironment Responsive Nanogel for the Combinatorial Antitumor Effect of Chemotherapy and Immunotherapy,Nano Letters, 2017, 17 (10): 6366-6375.(co-responding author)(IF:12.080,Most Read Articlesin Oct.) •Tan SW*,ZouCM, ZhangW, YinMX, GaoXQ,TangQ*,Recent developments in d-α-tocopheryl polyethylene glycolsuccinate-based nanomedicine for cancer therapy,Drug Delivery,2017,24(1):1831-1842.(co-responding author)(IF:3.095) •Yin MX#,Tan SW#, Bao YL,ZhangZP*. Enhanced tumor therapy via drug co-delivery and in situ vascular-promoting strategy,Journal of Controlled Release, 2017, 258:108-120.(#: equal contribution)(IF:7.877) •Yin MX, Bao YL, Gao XQ, Wu YP,Sun Y,Zhao Xy,Xu HZ,Zhang ZP*,Tan SW*. Redox/pH dual-sensitive hybrid micelles for targeting delivery and overcoming multidrug resistance of cancer,Journal of Materials Chemistry B, 2017, 5(16):2964-2978.(co-responding author)(IF:4.776) • Bao YL, Kong M, Gao XQ, Yin MX, Deng H, Tan Q, Wang Q*,Tan SW*,pH-, redox dual-sensitive poly(β-amino ester)-g-TPGS copolymer nanoparticles for drug delivery and inhibition of multidrug resistance in cancer,Reactive&Functional Polymers, 2017, 120,131-138.(co-responding author)(IF:2.975) • 孔苗,谭松巍*. 化疗药物在肿瘤免疫微环境调节中的应用.华中科技大学学报(医学版), 2017, 46(3): 352-359. (Responding author) • 关旸, 王林燕, 何冰倩,谭松巍*. 青蒿素及其衍生物纳米制剂在抗肿瘤领域中的研究进展.中国药师, 2017, 20(7): 1275-1278. (Responding author) • Bao YL, Yin MX, Hu XM, Zhuang XT, Sun Y, Guo YY,Tan SW*, ZhangZP*.ASafe,Simple andEfficientDoxorubicinProdrugHybridMicelle forOvercomingTumorMultidrugResistance andTargetingDelivery,Journal of Controlled Release, 2016, 235: 182-194;(co-responding author)(IF:7.786,ESI高被引论文) •Tan SW, Wu TT, Zhang Dand ZhangZP*,Cell or cell membrane-based drug delivery systems,Theranostics, 2015,5(8):863-881; (IF: 8.854,ESI高被引论文) •Bao YL, Guo YY, Zhuang XT, Li D, Cheng BL,Tan SW*, ZhangZP*. D‑α-Tocopherol Polyethylene Glycol Succinate-Based Redox-Sensitive Paclitaxel Prodrug for Overcoming Multidrug Resistance in Cancer Cells,Molecular Pharmaceutics,2014,11(9): 3196-3209;(co-responding author)(IF: 4.384,Most Read Articlesin Sep. & Oct.) •Tan SW#,Sasada T#, Bershteyn A, et al.CombinationalDelivery ofLipid-enveloped PLGANanoparticlesCarryingDifferentAntigenicEpitopes forInduction ofAnti-tumor immunity,Nanomedicine, 2014, 9: 635-647;(#: equal contribution)(IF:5.413)